Introduction: To avoid potential cardiovascular collapse after Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA), current guidelines recommend methodically deflating the balloon over 5 minutes to gradually reperfuse distal tissue beds. However, anecdotal evidence suggests that this approach may still result in unpredictable aortic flow rates and hemodynamic instability. We sought to characterize aortic flow dynamics following REBOA as the balloon is deflated in accordance with current practice guidelines. Methods: Eight Yorkshire-cross swine were splenectomized, instrumented, and subjected to rapid 25% total blood volume hemorrhage. After 30 minutes of shock, animals received 60 minutes of zone 1 REBOA with a low-profile REBOA catheter. During subsequent resuscitation with shed blood, the aortic occlusion balloon was gradually deflated in stepwise fashion at the rate of 0.5 mL every 30 seconds until completely deflated. Aortic flow rate and proximal mean arterial pressure (MAP) were measured continuously over the period of balloon deflation. Results: Graded balloon deflation resulted in variable initial return of aortic flow (median 78 seconds, IQR 68-105sec). A rapid increase in aortic flow during a single balloon deflation step was observed in all animals (Median 819 mL/min IQR 664-1241mL/min) and corresponded with an immediate decrease in proximal MAP (Median 30 mmHg IQR 14.5-37mmHg). Total balloon volume and time to return of flow demonstrated no correlation (r2=0.016). Conclusion: This study is the first to characterize aortic flow during balloon deflation following REBOA. A steep inflection point occurs during balloon deflation that results in an abrupt increase in aortic flow and a concomitant decrease in MAP. Furthermore, the onset of distal aortic flow was inconsistent across study animals and did not correlate with initial balloon volume or relative deflation volume. Future studies to define the factors that impact aortic flow during balloon deflation are needed to facilitate controlled reperfusion following REBOA. Level of Evidence: Level V (C) 2017 Lippincott Williams & Wilkins, Inc.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2onC0YQ
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: April 2016 Source: The Journal of Emergency Medicine, Volume 50, Issue 4 from Emergency Medicine via xlomafota13 on...
-
Abstract Purpose Enterobius vermicularis might be seen in specimens of patients who underwent surgery due to acute appendicitis. There is...
-
This feed no longer exists. Cambridge Journals Online and Cambridge Books Online have been replaced by Cambridge University Press’s new acad...
-
Abstract Herein, in this work we have developed macroporous nanocomposite of polyaniline (Pani) with nanodiamond (ND) and graphene (GN) by...
-
BACKGROUND: Irreversible hemorrhagic shock is characterized by hyporesponsiveness to vasopressor and fluid therapy. Little is known, however...
-
Midodrine is an oral agent which functions as an alpha-1 agonist. It has been used in a variety of situations including autonomic dysfuncti...
-
Objectives: Opioids and benzodiazepines are commonly used to provide analgesia and sedation for critically ill children with cardiac disease...
-
The duration of intra-abdominal hypertension and increased serum lactate level are important prognostic markers in critically ill surgical p...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου